Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study)

Scand J Gastroenterol. 2015;50(12):1456-62. doi: 10.3109/00365521.2015.1064991. Epub 2015 Jul 3.

Abstract

Objectives: Identifying ulcerative colitis (UC) patients with increased risk of colectomy is essential for appropriate treatment. We aimed to develop a prediction model assessing the risk of having colectomy within the first 10 years after diagnosis.

Material and methods: A population-based inception cohort of UC patients diagnosed in south-eastern Norway between 1990 and 1994 has been followed for 10 years. Altogether 519 patients were recruited including 49 patients who were colectomized. Based on the best-fitted multivariate model, the probabilities of colectomy were computed for selected levels of baseline covariates, and the results arranged in a prediction matrix. The following risk factors at diagnosis were analyzed: age, smoking, sex, disease extent, weight loss and fever and need for systemic steroids. Biochemical markers included C-reactive protein (CRP, <30 or ≥30 mg/l); erythrocyte sedimentation rate (ESR, <30 or ≥30 mm/h) and hemoglobin (Hgb, <10.5 or ≥ 10.5 g/dL).

Results: Extent of disease, age (<40 years, ≥40 years), need for systemic steroids and CRP or ESR (<30 or ≥30) at diagnosis were independently associated with colectomy and were combined in a prediction matrix. The probabilities of colectomy during the follow-up period ranged from 2.6% to 40.1% depending on the combination of predictors at diagnosis.

Conclusions: Our prediction model revealed significant differences in the probability of undergoing colectomy during a 10-years course of disease, which supports an early individualized treatment approach in UC.

Keywords: colectomy; population-based; prognosis; risk factors; ulcerative colitis.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood*
  • Blood Sedimentation
  • C-Reactive Protein / chemistry
  • Child
  • Child, Preschool
  • Cohort Studies
  • Colectomy / methods*
  • Colitis, Ulcerative / drug therapy*
  • Colitis, Ulcerative / surgery*
  • Female
  • Glucocorticoids / therapeutic use
  • Hemoglobins / chemistry
  • Humans
  • Logistic Models
  • Male
  • Mesalamine / therapeutic use
  • Middle Aged
  • Norway
  • Prognosis
  • Risk Factors
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome
  • Young Adult

Substances

  • Biomarkers
  • Glucocorticoids
  • Hemoglobins
  • Mesalamine
  • C-Reactive Protein